LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
27 funds hold it · Insiders net selling
Net selling: insiders sold $678K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.04 expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $1.12est. $1.04 | +7.83%beat | $416.2MSEC filing | +8.4%from $384.2M |
| Jun 30, 2026Reported Jul 30, 2026 | $1.19est. $0.96 | +24.02%beat | $418.8MSEC filing | +9.5%from $382.5M |
| Mar 31, 2026Reported Apr 30, 2026 | $0.94est. $0.83 | +12.80%beat | $381.9MAlpha Vantage | +7.8%from $354.3M |
| Dec 31, 2025Reported Feb 24, 2026 | $1.04est. $0.95 | +8.98%beat | $394.2MAlpha Vantage | +11.0%from $355.2M |
| Sep 30, 2025Reported Oct 30, 2025 | $0.92est. $0.83 | +10.84%beat | $384.2MSEC filing | +13.0%from $339.8M |
| Jun 30, 2025Reported Jul 30, 2025 | $1.01est. $0.85 | +18.82%beat | $382.5MSEC filing | +13.2%from $338.0M |
| Mar 31, 2025Reported Apr 24, 2025 | $0.86est. $0.75 | +14.67%beat | $354.3MAlpha Vantage | +9.5%from $323.5M |
| Dec 31, 2024Reported Feb 25, 2025 | $0.93est. $0.83 | +12.05%beat | $355.2MAlpha Vantage | +9.9%from $323.3M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $394.2M | $381.9M | $418.8M | $416.2M |
| Cost of what it sold | $198.7M | $197.1M | $203.7M | $215.6M |
| Gross profit | $195.4M | $184.8M | $215.2M | $200.6M |
| What it spent | ||||
| Research and development | $26.5M | $22.6M | $25.4M | $22.4M |
| Sales and admin | $114.8M | $118.2M | $129.2M | $46.9M |
| Other operating costs | — | — | — | $72.6M |
| Total operating expenses | $141.4M | $140.8M | $154.6M | $141.9M |
| What was left | ||||
| Operating profit | $54.1M | $44.0M | $60.5M | $58.8M |
| Interest on debt | $6.4M | $6.5M | $12.1M | $7.3M |
| Profit before tax | $51.1M | $53.5M | $51.3M | $55.8M |
| Tax | $13.1M | $12.6M | $12.5M | $13.5M |
| Net profit | $38.0M | $41.0M | $38.8M | $42.3M |
| EBITDA | $91.8M | $93.4M | $97.4M | $95.0M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Merit Medical presents real-world data from AVF cohort of WRAP Global registry
BullishNov 9Merit Medical Systems, Inc. (MMSI) Seasonal Returns Chart - Yahoo Finance
NeutralNov 7Here's Why You Should Retain MMSI Stock in Your Portfolio for Now
Leans bullishNov 6Merit Medical reports positive real-world data for dialysis device By Investing.com
BullishNov 5Merit Medical reports real-world patency data for its Wrapsody device
BullishNov 5Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
BullishNov 5Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
BullishNov 5Merit Medical Stock In Focus After Earnings Beat And Higher 2026 Guidance
BullishNov 5
